Table 2.
Characteristics of lung metastasis: pattern, treatment and outcome.
| Patient | Time to lung metastasis diagnosis (months) | Lung metastasis pattern | No. of RAI doses | Cumulative RAI doses | Structural outcome | Biochemical outcome |
|---|---|---|---|---|---|---|
| 1 | 3 | Macronodular | 1 | 150.00 | WBS+ | Persistent |
| 2 | 0 | Micronodular | 1 | 75.00 | NED | Unknown |
| 3 | 124 | Micronodular | 4 | 786.00 | NED | Persistent |
| 4 | 1 | Micronodular | 3 | 452.00 | CT+ | Persistent |
| 5 | 27 | Micronodular | 1 | 200.00 | CT+ | NED |
| 6 | 0 | Micronodular | 2 | 160.00 | WBS+ | Persistent |
| 7 | 23 | Micronodular | 2 | 399.00 | NED | Unknown |
| 8 | 0 | Micronodular | 5 | 835.00 | CT+ | Persistent |
| 9 | 14 | Micronodular | 2 | 300.00 | NED | Persistent |
| 10 | 32 | Micronodular | 3 | 466.79 | CT+ | Persistent |
| 11 | 2 | Micronodular | 2 | 412.80 | WBS+/CT+ | Persistent |
| 12 | 1 | Macronodular | 3 | 532.55 | CT+ | NED |
| 13 | 0 | Micronodular | 5 | 563.00 | WBS+ | Persistent |
| 14 | 0 | Micronodular | 4 | 557.00 | CT+ | Persistent |
| 15 | 0 | Micronodular | 4 | 380.00 | NED | Persistent |
| 16 | 35 | Micronodular | 2 | 198.50 | WBS+/CT+ | Persistent |
| 17 | 0 | Micronodular | 3 | 286.00 | CT+ | Persistent |
| 18 | 1 | Micronodular | 4 | 619.00 | CT+ | Persistent |
| 19 | 0 | Micronodular | 2 | 278.00 | WBS+ | Persistent |
| 20 | 0 | No apparent nodule | 1 | 123.00 | CT+ | Persistent |
| 21 | 4 | Micronodular | 1 | 125.00 | NED | NED |
| 22 | 61 | No apparent nodule | 3 | 400.00 | WBS+/CT+ | Persistent |
| 23 | 1 | No apparent nodule | 1 | 40.00 | CT+ | NED |
| 24 | 0 | Micronodular | 2 | 316.00 | WBS+ | Persistent |
| 25 | 0 | Micronodular | 3 | 483.00 | CT+ | Persistent |
| 26 | 0 | Micronodular | 3 | 258.00 | WBS+ | Persistent |
| 27 | 6 | Micronodular | 4 | 650.00 | CT+ | Persistent |
| Overall median | 3 | 380 |
NED, No evidence of disease.